TTA-A2

TTA-A2 is an antagonist of Calcium Channels and PXR used in studies of Calcium Signaling and Metabolic Signaling. It is especially relevant in cardiovascular, cell signaling, and endocrinology models, where defined compound exposure can be linked to calcium flux, excitability, and secretion-linked signaling and metabolic regulation, energy sensing, and enzyme-linked homeostasis.

By blocking Calcium Channels and PXR, TTA-A2 can be used to examine calcium flux, excitability, and secretion-linked signaling and metabolic regulation, energy sensing, and enzyme-linked homeostasis. The ion channel annotation adds relevance to electrophysiology, ion-flux, and membrane-potential studies, together with downstream-response mapping in the same experimental setting. In cardiovascular, cell signaling, and endocrinology models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.

Research Applications

• Target-focused assays involving Calcium Channels and PXR
• Pathway perturbation studies connected to Calcium Signaling and Metabolic Signaling
• Receptor-blockade and ligand-competition studies
• Electrophysiology, ion-flux, and membrane-potential studies

Overall, TTA-A2 is appropriate when a defined chemical perturbant is needed to connect Calcium Channels and PXR with measurable biochemical, transcriptional, electrophysiological, imaging, or phenotypic readouts in cardiovascular, cell signaling, and endocrinology models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.